Efficacy and safety of butylphthalide in patients with mild cognitive impairment: a multicentre, randomised, double-blind, placebo-controlled trial (EBMCI study)
Introduction The efficacy of multitarget neuroprotective drug DL-3-n-butylphthalide (NBP) in improving cognitive function has been confirmed in patients with vascular cognitive impairment without dementia. However, its efficacy in patients with symptomatic predementia phase of Alzheimer’s disease re...
Saved in:
| Main Authors: | Pin Wang, Chang Xu, Yufei Chen, Yuting Yang, Jin Gong, Wenxian Sun, Xiaodong Han, Heya Luan, Shaoqi Li, Ruina Li, Boye Wen, Sirong Lv, Cuibai Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/7/e082404.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
by: Maki Komiyama, et al.
Published: (2023-04-01) -
Nitroglycerin for treatment of retained placenta: A randomised, placebo-controlled, multicentre, double-blind trial in the UK.
by: Fiona C Denison, et al.
Published: (2019-12-01) -
Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial
by: Yumeng Ju, et al.
Published: (2025-03-01) -
EFFICACY AND TOLERABILITY OF LERCANIDIPINE IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION IN A PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
by: M. A. Ninci, et al.
Published: (2016-01-01) -
A Randomized, Double-Blind, Placebo-Controlled, Multicentre Trial of the Effects of a Shrimp Protein Hydrolysate on Blood Pressure
by: Kathy Musa-Veloso, et al.
Published: (2019-01-01)